CCK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Crown Holdings Inc (CCK) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has a solid market position in the packaging industry, its recent financial performance shows significant declines in net income and EPS. Additionally, hedge funds are selling the stock, and there are no strong proprietary trading signals to suggest immediate action. Analysts' ratings are mixed, with some downgrades citing valuation concerns. The technical indicators suggest a neutral trend, and options data does not indicate strong bullish sentiment. For a long-term investor, it may be better to wait for clearer positive catalysts or improved financial performance before investing.
The MACD is positive and expanding, indicating a potential upward trend. However, the RSI is neutral at 54.162, and moving averages are converging, suggesting no clear directional signal. Key support and resistance levels are at 98.113 and 103.851, respectively. The stock is trading near its resistance level, which may limit immediate upside potential.
The company is a leading global supplier of rigid packaging products, maintaining a strong market position. Analysts have set higher price targets in the range of $120-$140, indicating potential upside in the long term. The company has guided for improved earnings growth in FY27.
Hedge funds are selling the stock, with a significant increase in selling activity. Financial performance in Q4 2025 showed a sharp decline in net income (-58.10% YoY) and EPS (-56.62% YoY). Analysts have downgraded the stock, citing valuation concerns and potential multi-year lower volume growth. Options data does not indicate strong bullish sentiment.
In Q4 2025, revenue increased by 7.72% YoY to $3.127 billion. However, net income dropped by 58.10% YoY to $150 million, and EPS decreased by 56.62% YoY to $1.31. Gross margin also declined to 17.46%, down 7.18% YoY. The financial performance reflects cost pressures and challenges in the packaging industry.
Analysts' ratings are mixed. Deutsche Bank initiated coverage with a Buy rating and a $124 price target. RBC Capital raised its price target to $140 with an Outperform rating. However, UBS downgraded the stock to Neutral, citing balanced risk/reward. JPMorgan and Wolfe Research also downgraded the stock, citing valuation concerns and flat earnings growth in 2026.
